Long Term Subcutaneous Tinzaparin [tinzaparin sodium] Compared With Tinzaparin and Oral Anticoagulants [acenocoumarol] in the Treatment of the Acute Pulmonary Embolism.
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Acenocoumarol; Tinzaparin sodium
- Indications Pulmonary embolism
- Focus Adverse reactions
- 12 Feb 2009 Actual patient numbers (102) added as reported by ClinicalTrials.gov.
- 12 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jul 2008 New trial record.